葛兰素史克(GSK):欧盟委员会批准Nucala用于未受控的慢性阻塞性肺病

金吾财讯
Feb 06

金吾财讯 | 葛兰素史克(GSK)宣布,欧盟委员会已批准其单克隆抗体维持治疗药物Nucala用于未受控的慢性阻塞性肺病。该批准基于MATINEE III期试验的积极数据,其中在广泛具有嗜酸性粒细胞表型的COPD患者中,mepolizumab与安慰剂加标准护理相比,显示出在中度/重度急性加重年化率上的临床意义和统计学显著降低。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10